{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:04:23Z","timestamp":1784808263946,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.meddos.2023.07.004","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T15:08:14Z","timestamp":1693667294000},"page":"286-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quality rectal hydrogel placement allows for gel-enabled dose-escalated EBRT (GEDE-EBRT) without rectal interference in prostate cancer"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8265-3328","authenticated-orcid":false,"given":"Jamie S.K.","family":"Takayesu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0975-7663","authenticated-orcid":false,"given":"Patrick","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrinda","family":"Narayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.meddos.2023.07.004_bib0001","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ijrobp.2008.02.073","article-title":"Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer","volume":"72","author":"Al-Mamgani","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.meddos.2023.07.004_bib0002","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.meddos.2023.07.004_bib0003","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.meddos.2023.07.004_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijrobp.2019.11.415","article-title":"Radiation dose escalation or longer androgen suppression to prevent distant progression in men with locally advanced prostate cancer: 10-year data from the TROG 03.04 RADAR trial","volume":"106","author":"Joseph","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.meddos.2023.07.004_bib0006","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: Results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.meddos.2023.07.004_bib0007","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2020.03.015","article-title":"Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer","volume":"147","author":"Draulans","year":"2020","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijrobp.2022.09.058","article-title":"Standard and hypofractionated dose escalation to intraprostatic tumor nodules in localized prostate cancer: 5-year efficacy and toxicity in the DELINEATE trial","volume":"115","author":"Tree","year":"2023","journal-title":"Int. J. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.meddos.2023.07.004_bib0009","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2020.06.072","article-title":"Knowledge-based assessment of focal dose escalation treatment plans in prostate cancer","volume":"108","author":"van Schie","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0010","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.meddos.2023.07.004_bib0011","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.urology.2021.05.013","article-title":"SpaceOAR hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review","volume":"156","author":"Armstrong","year":"2021","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.meddos.2023.07.004_bib0012","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.adro.2019.08.007","article-title":"Assessment of polyethylene glycol hydrogel spacer and its effect on rectal radiation dose in prostate cancer patients receiving proton beam radiation therapy","volume":"5","author":"Navaratnam","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"issue":"9","key":"10.1016\/j.meddos.2023.07.004_bib0013","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00066-013-0388-0","article-title":"Treatment planning after hydrogel injection during radiotherapy of prostate cancer","volume":"189","author":"Pinkawa","year":"2013","journal-title":"Strahlenther. Onkol"},{"issue":"1","key":"10.1016\/j.meddos.2023.07.004_bib0014","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12885-018-4511-6","article-title":"PROstate Multicentre External beam radioTHErapy using a stereotactic boost: The PROMETHEUS study protocol","volume":"18","author":"Richardson","year":"2018","journal-title":"BMC Cancer"},{"issue":"7-8","key":"10.1016\/j.meddos.2023.07.004_bib0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5489\/cuaj.3236","article-title":"Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens","volume":"10","author":"Paterson","year":"2016","journal-title":"Can. Urol. Assoc. J."},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0016","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijrobp.2009.02.019","article-title":"Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy","volume":"76","author":"McLaughlin","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2023.07.004_bib0017","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1745-6215-12-255","article-title":"Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): Study protocol for a randomized controlled trial","volume":"12","author":"Lips","year":"2011","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0018","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1120\/jacmp.v16i2.5013","article-title":"Intrafractional prostate motion during external beam radiotherapy monitored by a real-time target localization system","volume":"16","author":"Tong","year":"2015","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.meddos.2023.07.004_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac","volume":"151","author":"de Muinck Keizer","year":"2020","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ijrobp.2007.05.002","article-title":"Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes","volume":"69","author":"Stone","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0021","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0360-3016(98)00089-3","article-title":"Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions","volume":"41","author":"Hanks","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.meddos.2023.07.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: The NRG Oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2023.07.004_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2009.01.062","article-title":"Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I\/II dose escalation study","volume":"76","author":"Michalski","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2023.07.004_bib0024","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13014-021-01933-z","article-title":"Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer","volume":"16","author":"Tamihardja","year":"2021","journal-title":"Radiat. Oncol. Lond. Engl."},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0025","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2022.04.020","article-title":"PSMA-PET- and MRI-based focal dose escalated radiation therapy of primary prostate cancer: Planned safety analysis of a nonrandomized 2-armed phase 2 trial (ARO2020-01)","volume":"113","author":"Zamboglou","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2023.07.004_bib0026","article-title":"Local failure after prostate SBRT predominantly occurs in the PI-RADS 4 or 5 dominant intraprostatic lesion","author":"Gorovets","year":"2022","journal-title":"Eur. Urol. Oncol."},{"issue":"4","key":"10.1016\/j.meddos.2023.07.004_bib0027","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2015.04.111","article-title":"Patterns of local failure following radiation therapy for prostate cancer","volume":"194","author":"Jalloh","year":"2015","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0028","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2023.07.004_bib0029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clgc.2015.12.005","article-title":"Radiotherapy boost for the dominant intraprostatic cancer lesion: A systematic review and meta-analysis","volume":"14","author":"von Eyben","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0031","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.prnil.2018.03.005","article-title":"Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: A systematic review","volume":"6","author":"Feutren","year":"2018","journal-title":"Prostate Int."},{"issue":"4","key":"10.1016\/j.meddos.2023.07.004_bib0032","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2006.10.026","article-title":"Multi-institutional clinical experience with the Calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy","volume":"67","author":"Kupelian","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0033","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: The MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0034","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.brachy.2020.06.011","article-title":"Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy","volume":"19","author":"Boyce-Fappiano","year":"2020","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0090-4295(83)90038-9","article-title":"Pelvic complications after definitive treatment of prostate cancer by interstitial or external beam radiation","volume":"21","author":"Schellhammer","year":"1983","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0036","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: Implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2023.07.004_bib0037","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0038","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2023.07.004_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01174","article-title":"Increased dose to organs in urinary tract associates with measures of genitourinary toxicity in pooled voxel-based analysis of 3 randomized phase III trials","volume":"10","author":"Marcello","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0360-3016(01)01475-4","article-title":"A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction","volume":"50","author":"Merrick","year":"2001","journal-title":"Int. J. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0041","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1538-4721(02)00018-1","article-title":"Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy","volume":"1","author":"Kiteley","year":"2002","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.meddos.2023.07.004_bib0042","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0360-3016(00)00746-X","article-title":"A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction","volume":"48","author":"Merrick","year":"2000","journal-title":"Int. J. Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0043","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0090-4295(01)00940-2","article-title":"Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer","volume":"57","author":"Fisch","year":"2001","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.meddos.2023.07.004_bib0044","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0360-3016(99)00551-9","article-title":"Brachytherapy radiation doses to the neurovascular bundles","volume":"46","author":"DiBiase","year":"2000","journal-title":"Int. J. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2005.02.036","article-title":"Functional anatomy of the prostate: Implications for treatment planning","volume":"63","author":"McLaughlin","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0046","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.brachy.2021.11.003","article-title":"Rectal sparing in prostate radiotherapy with combination-brachytherapy and hydrogel spacer","volume":"21","author":"Cousins","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.meddos.2023.07.004_bib0047","series-title":"JAMA Oncol","article-title":"Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial","author":"Mariados","year":"2023"},{"issue":"2","key":"10.1016\/j.meddos.2023.07.004_bib0048","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.prro.2021.09.015","article-title":"Feasibility of same-day prostate fiducial markers, perirectal hydrogel spacer placement, and computed tomography and magnetic resonance imaging simulation for external beam radiation therapy for low-risk and intermediate-risk prostate cancer","volume":"12","author":"Brenneman","year":"2022","journal-title":"Pract. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0049","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-5347(01)65645-3","article-title":"Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer","volume":"156","author":"Goldenberg","year":"1996","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.meddos.2023.07.004_bib0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jcp.55.7.508","article-title":"Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer","volume":"55","author":"Selli","year":"2002","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.meddos.2023.07.004_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2016.09.006","article-title":"American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer","volume":"16","author":"Spratt","year":"2017","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.meddos.2023.07.004_bib0052","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mrm.23062","article-title":"DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: A feasibility study","volume":"67","author":"Barrett","year":"2012","journal-title":"Magn. Reson. Med."}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394723000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394723000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:39:23Z","timestamp":1784806763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394723000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"alternative-id":["S0958394723000651"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2023.07.004","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality rectal hydrogel placement allows for gel-enabled dose-escalated EBRT (GEDE-EBRT) without rectal interference in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2023.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Association of Medical Dosimetrists.","name":"copyright","label":"Copyright"}]}}